Literature DB >> 1328249

Type IV collagen stimulates an increase in intracellular calcium. Potential role in tumor cell motility.

D M Savarese1, J T Russell, A Fatatis, L A Liotta.   

Abstract

Type IV collagen (Coll IV), a component of the extracellular matrix, stimulates motility in the A2058 human melanoma cell line, a response that is inhibited by pertussis toxin (PT). Fibronectin (FN)-induced chemotaxis in this cell line is not affected by PT. To understand the mechanism of cellular signaling, single cell intracellular Ca2+ responses to Coll IV and FN were studied using Fura-2 and digital imaging fluorescence microscopy. Coll IV, at a dose that stimulates motility (100 micrograms/ml, 185 nM), induces a significant rise in cytosolic free Ca2+ concentration ([Ca2+]i) within 100 s. This response is not inhibited by PT. Treatment of the cells with FN 30 micrograms/ml (70 nM), a dose that stimulates near-maximal chemotaxis, does not increase [Ca2+]i appreciably. Removal of extracellular Ca2+ fails to inhibit the Coll IV-stimulated rise in Ca2+ in all cells. Depletion of extracellular Ca2+ and pretreatment of cells with Ca2+ channel blockers only partially inhibits Coll IV-induced motility. Depletion of intracellular Ca2+ inhibits both chemotaxis and the Coll IV-induced increase in intracellular Ca2+. Coll IV does not stimulate membrane phosphoinositide hydrolysis. We conclude that Coll IV treatment induces an inositol 1,4,5-trisphosphate-independent release of intracellular Ca2+ stores which appears to play a necessary role in the chemotactic response of A2058 cells but is not mediated by a PT-sensitive G-protein. This response is not seen in cells exposed to FN, suggesting different intracellular signaling mechanisms for stimulated motility between these two extracellular matrix molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Use of green fluorescent protein-conjugated beta-actin as a novel molecular marker for in vitro tumor cell chemotaxis assay.

Authors:  L Hodgson; W Qiu; C Dong; A J Henderson
Journal:  Biotechnol Prog       Date:  2000 Nov-Dec

2.  Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.

Authors:  Hiroshi Nozawa; Gina Howell; Shinsuke Suzuki; Qing Zhang; Yanjun Qi; Judith Klein-Seetharaman; Alan Wells; Jennifer R Grandis; Sufi M Thomas
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

3.  The differential effect of endothelial cell factors on in vitro motility of malignant and non-malignant cells.

Authors:  Adele Wright; Yu-Hua Li; Cheng Zhu
Journal:  Ann Biomed Eng       Date:  2008-04-09       Impact factor: 3.934

4.  [Ca2+]i as a potential downregulator of alpha2beta1-integrin-mediated A2058 tumor cell migration to type IV collagen.

Authors:  L Hodgson; C Dong
Journal:  Am J Physiol Cell Physiol       Date:  2001-07       Impact factor: 4.249

5.  Acidic pH enhances the invasive behavior of human melanoma cells.

Authors:  R Martínez-Zaguilán; E A Seftor; R E Seftor; Y W Chu; R J Gillies; M J Hendrix
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

6.  Extracellular lipid-mediated signaling in tumor-cell activation and pseudopod protrusion.

Authors:  L Hodgson; E C Kohn; C Dong
Journal:  Int J Cancer       Date:  2000-11-15       Impact factor: 7.396

7.  Exposure to host ligands correlates with colocalization of Gal/GalNAc lectin subunits in lipid rafts and phosphatidylinositol (4,5)-bisphosphate signaling in Entamoeba histolytica.

Authors:  Amanda M Goldston; Rhonda R Powell; Amrita B Koushik; Lesly A Temesvari
Journal:  Eukaryot Cell       Date:  2012-04-13

8.  Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension.

Authors:  Anita Umesh; Omkar Paudel; Yuan-Ning Cao; Allen C Myers; James S K Sham
Journal:  J Vasc Res       Date:  2011-08-10       Impact factor: 1.934

9.  Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

Authors:  Adriana Casas; Gabriela Di Venosa; Silvia Vanzulli; Christian Perotti; Leandro Mamome; Lorena Rodriguez; Marina Simian; Angeles Juarranz; Osvaldo Pontiggia; Tayyaba Hasan; Alcira Batlle
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

Review 10.  Calcium-mediated signal transduction: biology, biochemistry, and therapy.

Authors:  K Cole; E Kohn
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.